Code of Conduct

• We do not tell a reader what to take. That decision belongs to a prescriber and the reader.
• We do not invent urgency. No countdowns, no “only today” offers.
• The exit prompt on seller lists and seller pages appears at most once a week, and once per visit. Closing it ends it.
• We do not ask readers for health information. We have no form that could collect it.

A seller is described by what it publishes. Its prices come from its own pages. Its regulatory position comes from FDA documents.

A seller that disputes a fact is heard. The fact changes when the seller’s public site or an FDA document shows it is wrong.

A commission can place a seller first in a list, with a Partner label. It cannot:

• change a peptide’s regulatory status;
• put a price or a seller link on a research-only peptide;
• change a published price;
• change what the research section says.

The scoring code that orders sellers after the partner group does not read commercial status. A test checks that flipping it leaves every score unchanged.

No invented figures. No citation from memory. No animal result written as a human one. The editorial policy sets out how each is applied.

1. Anyone can report a breach to the address below.
2. We check the page against the rule.
3. If the rule was broken, the page is fixed.
4. The reporter gets a reply saying what changed.